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PRO data into care processes and assess how the use of PRO in 
clinical care impacts on patient outcomes. 
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Purpose: To describe the case mix, intervention efficacy and 
prognosis of patients with advanced lung cancer attending a Fast 
Track Lung (FTL) clinic that was established to improve 
timeliness of access to palliative RT. 
Methods and Materials: Pre-treatment and treatment 
information was prospectively collected on FTL patients seen 
from January 2014 to December 2015. Palliative RT use was 
decided based on clinical/radiologic information suggesting that 
one or more specific symptoms were reasonably likely to be 
helped. Phone follow up by a nurse 1- 2 months later assessed 
the effect of RT on each index symptom. 
Results: Two hundred and fourteen patients were assessed a 
total of 310 times, a mean of 1.5 times per patient (range 1- 8). 
Eighty-six percent had non-small cell histologies (71% 
adenocarcinoma, 22% squamous cell carcinoma). Most were 
ECOG 2 (30%) or 3 (46%) at the time of first presentation. Median 
survival from initial FTL consult was 3.2 months (95% CI 2.2 – 3.6) 
for the entire group; for ECOG 0 – 1, it was 12.3 months (95% CI 
7.4 – 16.2) and for ECOG 3 – 4, 1.8 months (95% CI 1.5 – 2.2). 
EGFR mutation positive patients had a median survival of 12.5 
months (95% CI 4.3 – 39.8). 224 of the 310 clinic visits resulted in 
palliative RT to at least one site, of which 161 (72%) had phone 
follow up. Three hundred and ninety courses of RT were 
delivered, a mean of 1.8 per patient, (range 0 – 13). Forty-nine 
percent of RT courses were delivered to bony sites other than 
ribs, 22% to the chest, 14% to the chest wall/ribs and 10% to the 
brain. Thirty-once percent were single fractions and 92% were < 
5 fractions. Median dose was 20 Gy and the median number of 
fractions was 5. Among patients receiving RT to one or more 
concurrent site(s), 80% reported some benefit. Seventy-seven 
percent of patients receiving RT to the chest reported 
improvement in at least one index symptom. This varied by 
symptom (e.g. dysphagia 33%, cough 82%, hemoptysis 100%). 
Eighty percent of treated bone mets became less painful. If one 
assumes that every patient without follow up information had no 
benefit, still 59% were helped. 
Conclusions: Palliative RT, generally with 5 or fewer fractions, 
helped most patients with clinically or radiologically targetable 
symptoms who attended a dedicated Fast Track Lung clinic. 
Phone follow up is a feasible way to obtain patient or family 
reported outcome information. Median survival was short, 
although considerably longer in patients with good performance 
status and/or an EGFR mutation, in whom the potential benefits 
of more intensified palliative RT should be investigated.  
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Purpose: An interdisciplinary clinic was established at our 
regional cancer centre in 2011 for patients diagnosed with brain 
metastases. A clinic nurse/clinical nurse specialist, a spiritual 
care/patient-family counselor, a palliative care physician or 
nurse practitioner, and a radiation oncologist provided team-
based consultations. Other clinical or support services were 
engaged as needed. A self-administered feedback survey was 
given to the patient/family after consultation for quality 
improvement and program evaluation. We summarized the 
feedback, with an examination of themes that emerged through 
the comments given. 
Methods and Materials: Between July 2012 and December 2015, 
384 patients with/without family caregivers were seen at our 
outpatient palliative brain metastases clinic for consultation and 
management. A post-consultation feedback questionnaire, 
developed by team consensus, was framed to solicit satisfaction 
with: a) understanding of illness and options; b) symptom 
control; c) decision making; and d) care coordination. Items were 
rated on a 5-point Likert scale, anchored between “Strongly 
Agree” and “Strongly Disagree”. A free text comment section 
was also included. Questionnaires were given at the end of 
consultation with a self-addressed and stamped envelope for 
anonymous return. Numeric results are summarized in a 
frequency table and written comments are encoded by key words 
that indicate values and preferences. 
Results: Eighty-four questionnaires were received (22% response 
rate), 51/84 (61%) with written comments (median word count 
26, maximum 139). Satisfaction (“agree” or “strongly agree”) 
was indicated in 85% or more of questionnaires for 11 of 13 items. 
In contrast, dissatisfaction (“disagree” or “strongly disagree”) 
was indicated in less than 10% of questionnaires returned. The 
item of most dissatisfaction (9% of questionnaires) was about 
receiving “as much information about my prognosis as I wanted.” 
The most common key words of value were team approach, 
informative, respect, and professionalism. Comments expressing 
frustrations included poor communication, lack of clarity of 
treatment impact on prognosis, waiting time for care facility, 
tiring consultation process, missing prescription, and discrepancy 
between anticipated and actual cause of death.  
Conclusions: Interdisciplinary, team-based consultation and 
care was rated highly among questionnaire respondents 
confronting the diagnosis of brain metastases, a serious and life-
limiting illness. A small proportion of patients and families 
experienced gaps in communication and expectations. Team-
approach, information and respect appeared to be the most 
valued features of our consultative process. 
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Purpose: A provincial initiative to streamline and standardize 
radiation therapy (RT) processes was initiated in Q1 2015 with 
the ultimate goal of measuring treatment and operational 
outcomes. Two tertiary centres using Varian’s Record and Verify 
systems since the 1980’s have been slow to incorporate some of 
the paper-light functions and features available. Two community 
centres (opening in 2010 and 2014) introduced more of a paper-
light environment. The operational and environmental 
differences between facilities have resulted in disparate 
processes, software, and definitions in RT practice across the 
province. 
Methods and Materials: The first challenge was to establish a 
provincial Steering Committee (SC) with front-line 
representatives from each of three disciplines and all four RT 
facilities. The SC is comprised of: three co-chairs (medical 
physicist, radiation oncologist and radiation therapist), five 
0.2/0.4 FTE project coordinators (PC) (radiation therapists), 0.5 
FTE project manager (PM), two 0.5 FTE process improvement 
specialists (PIs) (one for the North and one for the South), a 
Varian Clinical Consultant, Executive sponsors, and additional 
representatives from each discipline at each RT centre. A core 
group (CG) of the SC consists of three co-chairs, PM, PCs, PIs, 
and Varian. Local working groups were established at each RT 
center with three co-chairs, who also sit on the SC to ensure 
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reliable communication and consistent goals. The second 
challenge was to provide a province-wide repository for sharing 
information and facilitating communication. In parallel with 
addressing these challenges, developmental work on 
streamlining and standardizing the RT process occurred. 
Results: The initial SC was assembled in Q1 2015; and full 
assembly of the SC and CG was completed in Q1 2016. The CG 
meets virtually on a weekly basis. The SC meets every ~6 weeks. 
Every second SC meeting is face-to-face at alternating RT centre 
locations. A Sharepoint site, accessible both inside and outside 
the organizational network, provides a central repository for 
information. RT process developments to-date include: 1) 
standard use of ARIA RO V11 MR 5.2 Prescribed Treatment 
workspace; 2) the entry of Diagnosis and Staging in ARIA RO; 3) 
standard definitions for a number of variables in our provincial 
minimum dataset; and 4) generation of an End of Treatment 
summary in ARIA RO with future distribution to other systems. 
Conclusions: The participation of all disciplines and facilities 
involved in the radiotherapy process is essential. Collaboration 
and communication between the four RT centres has greatly 
improved because of this project. North and South ARIA RO are 
now utilizing the same software versions and are converging in 
processes, carepaths, and definitions. The SC and CG provide a 
radiation oncology voice for communication with other provincial 
cancer control and healthcare initiatives. 
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Purpose: In 2011 the Canadian Partnership for Quality 
Radiotherapy (CPQR) released Quality Assurance Guidelines for 
Canadian Radiation Treatment Programs (QRT) recommending 
key quality indicators (KQI) of high quality, safe radiotherapy 
(RT). As it is unknown to what degree radiation oncology 
programs (ROP) use the guideline or meet these KQIs, we 
conducted a survey of Canadian ROPs to ascertain current 
guideline use and perceived barriers to its use as a self-auditing 
quality improvement (QI) tool.  
Methods and Materials: An invitation to participate was sent May 
2015 to all Canadian ROPs through their local CPQR 
representatives requesting one response per ROP (completed by 
December 2015). Each ROP was asked about use of the QRT 
document comprised of 47 KQI: 34 KQI scored as 0 (no) or1 (yes), 
and 13 KQI scored as a continuous variable of percentage 
compliance. To inquire about perceived barriers to unmet KQIs, 
personalized surveys were issued to each ROP based on results of 
their submitted self-audit of guideline KQIs.  
Results: The majority of ROPs completed the requested 
guideline self-audit (n = 44/45, 98%), with most (75%, 33/44) 
indicating previous use of the QRT. ROPs in the Prairies and 
Quebec accounted for 82% of centres (9/11) reporting no 
previous QRT use. Across ROP, there was a range of compliance 
for the 34 KQI scorable as 0 (no) or 1 (yes) (median 31/34, range 
19-34). Those binary KQIs identified as the most challenging 
included #22 (frequent policy and procedure review) with 50% 
compliant ROP (22/44) and #17 (RTQAC monitoring of technical 
quality control) with 66% compliant ROP (29/44). All 44 
responding ROP reported compliance with the following KQI: #32 
(RT prescription), #39 (on RT patient evaluation), #41 
(emergency RT policies/procedures) and #42 (RT plan record 
maintenance). Of the KQIs scored as a continuous variable, 
compliance was highest (100% median, range 60-100%) for #10 
(radiation oncologist certification) and lowest (median 50%, 
range 10-100%) for #33 (peer review pre-RT start). Two KQI 
appear particularly challenging, with only 59% (26/44) and 57% 
(25/44) of ROP responding regarding #44 (toxicity outcomes, 
median 30% ROP score, range 0-100%) and #45 (disease 
control/survival outcomes, median 25% ROP score, range 0-
100%), respectively. Commonly perceived barriers included lack 
of resources, data tracking ability or even disagreement with 
certain KQI. Many centres reported progress with unfulfilled 
KQIs, of which #2 and #3 (RTQAC monitoring and terms of 
reference) were most commonly cited. 
Conclusions: Since initial release of CPQR QRT, the majority of 
Canadian ROPs have used the guideline at least once to perform 
a quality self-audit. There are, however, gaps in guideline use 
and variations among centres in terms of KQI compliance. Future 
studies of potential facilitators to KQI uptake are warranted, as 
knowledge of perceived barriers may inform future strategies for 
optimizing QI initiatives across Canadian ROP. 
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DEVELOPMENT OF FUTURE LEADERS: RESULTS OF A PAN 
CANADIAN SURVEY  
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Purpose: To evaluate leadership models in Canadian cancer 
centres, and assess leadership development programs within 
these centres.  
Methods and Materials: This mixed methods health services 
study was performed between August and October 2015 by the 
leadership of a Canadian cancer centre. It used literature 
review, a pan-Canadian survey and structured interviews with 
fifty administrative leads of free standing cancer centres 
registered with the Canadian Association of Provincial Cancer 
Agencies (40 invited to complete a written survey; 10 phone 
interviews). The survey consisted of 26 questions organized 
into categories such as: rating of current leadership; 
important elements of leadership; traits that identify emerging 
leaders; the use of competency frameworks to evaluate 
leaders and the availability of programs to improve skills in 
leaders. 
Results: Twenty three of the potential 50 participants (46%) 
provided responses including representation from all provinces. 
Synthesis of responses provided the following insights: 1) there 
is strong consensus about the effectiveness of current leaders 
and which elements of leadership are considered important; 2) 
good agreement was reached on the traits that identify emerging 
leaders; 3) it was clear that competency frameworks are not 
employed consistently. Fewer than 70% of respondents used the 
LEADS tool to evaluate their leaders; and 4) none of the 
respondents used formal succession planning tools. 75% of 
respondents did not systematically offer skill development 
programs to their leaders.  
Conclusions: Although current leaders are perceived as doing 
well at leading, there seemed to be several gaps needing 
attention. Firstly, there does not appear to be a consistent 
expectation of leaders needing to be regularly evaluated. 
Secondly, it is concerning that administrative and medical 
leaders within a significant number of Canadian cancer centres 
do not see the importance of providing opportunities to leaders 
that would maximize their skills to lead teams or drive innovative 
change. For cancer programs to thrive there needs to be greater 
attention to develop emerging leaders. 
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